17,653 Colgate-Palmolive Company $CL Shares Bought by Atwood & Palmer Inc.

Atwood & Palmer Inc. lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 67.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,853 shares of the company’s stock after purchasing an additional 17,653 shares during the quarter. Atwood & Palmer Inc.’s holdings in Colgate-Palmolive were worth $3,742,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. YHB Investment Advisors Inc. boosted its stake in Colgate-Palmolive by 388.0% during the 3rd quarter. YHB Investment Advisors Inc. now owns 51,377 shares of the company’s stock valued at $4,383,000 after purchasing an additional 40,850 shares in the last quarter. Apella Capital LLC raised its stake in shares of Colgate-Palmolive by 312.2% in the 3rd quarter. Apella Capital LLC now owns 18,033 shares of the company’s stock worth $1,539,000 after buying an additional 13,658 shares in the last quarter. Everhart Financial Group Inc. raised its position in Colgate-Palmolive by 88.1% in the third quarter. Everhart Financial Group Inc. now owns 8,694 shares of the company’s stock worth $742,000 after acquiring an additional 4,072 shares in the last quarter. Avidian Wealth Enterprises LLC lifted its holdings in Colgate-Palmolive by 89.1% in the 3rd quarter. Avidian Wealth Enterprises LLC now owns 19,297 shares of the company’s stock valued at $1,646,000 after acquiring an additional 9,094 shares during the last quarter. Finally, Veracity Capital LLC grew its stake in shares of Colgate-Palmolive by 48.7% in the 3rd quarter. Veracity Capital LLC now owns 11,169 shares of the company’s stock worth $953,000 after purchasing an additional 3,660 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on CL shares. Barclays increased their target price on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Morgan Stanley reaffirmed an “overweight” rating and issued a $104.00 price target on shares of Colgate-Palmolive in a report on Monday, August 3rd. TD Cowen raised their price objective on Colgate-Palmolive from $85.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Finally, JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a report on Monday, August 3rd. Twelve investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $98.65.

Colgate-Palmolive Trading Up 1.0%

NYSE CL traded up $0.86 on Thursday, hitting $88.07. 4,080,637 shares of the stock were exchanged, compared to its average volume of 5,703,748. The company’s 50-day moving average price is $89.23 and its two-hundred day moving average price is $88.75. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a market capitalization of $70.21 billion, a price-to-earnings ratio of 34.95, a P/E/G ratio of 4.07 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. The company had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The company’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.92 earnings per share. Research analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is 84.13%.

Insider Buying and Selling

In related news, Director John Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the transaction, the chief operating officer owned 64,901 shares in the company, valued at $5,974,137.05. This trade represents a 13.35% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 175,191 shares of company stock worth $16,110,903. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.